1. Home
  2. BCAB vs NVFY Comparison

BCAB vs NVFY Comparison

Compare BCAB & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • NVFY
  • Stock Information
  • Founded
  • BCAB 2007
  • NVFY 2003
  • Country
  • BCAB United States
  • NVFY United States
  • Employees
  • BCAB N/A
  • NVFY N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • NVFY Home Furnishings
  • Sector
  • BCAB Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • BCAB 21.6M
  • NVFY 25.5M
  • IPO Year
  • BCAB 2020
  • NVFY N/A
  • Fundamental
  • Price
  • BCAB $0.45
  • NVFY $1.95
  • Analyst Decision
  • BCAB Hold
  • NVFY
  • Analyst Count
  • BCAB 3
  • NVFY 0
  • Target Price
  • BCAB $1.00
  • NVFY N/A
  • AVG Volume (30 Days)
  • BCAB 561.4K
  • NVFY 629.7K
  • Earning Date
  • BCAB 08-07-2025
  • NVFY 08-14-2025
  • Dividend Yield
  • BCAB N/A
  • NVFY N/A
  • EPS Growth
  • BCAB N/A
  • NVFY N/A
  • EPS
  • BCAB N/A
  • NVFY N/A
  • Revenue
  • BCAB $11,000,000.00
  • NVFY $9,813,990.00
  • Revenue This Year
  • BCAB N/A
  • NVFY N/A
  • Revenue Next Year
  • BCAB N/A
  • NVFY N/A
  • P/E Ratio
  • BCAB N/A
  • NVFY N/A
  • Revenue Growth
  • BCAB N/A
  • NVFY N/A
  • 52 Week Low
  • BCAB $0.24
  • NVFY $0.39
  • 52 Week High
  • BCAB $2.53
  • NVFY $3.59
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 65.33
  • NVFY 49.07
  • Support Level
  • BCAB $0.35
  • NVFY $1.56
  • Resistance Level
  • BCAB $0.38
  • NVFY $2.40
  • Average True Range (ATR)
  • BCAB 0.03
  • NVFY 0.22
  • MACD
  • BCAB 0.01
  • NVFY -0.00
  • Stochastic Oscillator
  • BCAB 90.66
  • NVFY 54.55

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: